← Spire Therapeutics
What podcasts say about Spire Therapeutics
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Spire Therapeutics
1 statement · 1 negative
Spire Therapeutics’ drug missed its internal monotherapy-development threshold.
“the drug kind of fell short of the company's internal bar for developing it as a monotherapy.”
Open the episode · Intuit Slumps, Spyre Therapeutics Mixed, Dick's Sporting Goods SlidesListen at 2:01
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.